Bayer, Curadev ink pact to discover drug candidates for lung, cardiovascular, inflammatory diseases
Posted by
www.biotecnika.org
Global pharma and life sciences major Bayer and domestic drug
discovery firm Curadev have signed a research collaboration and
licence agreement to discover new drug candidates for treatment of
lung, cardiovascular and inflammatory diseases.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bayer-curadev-ink-pact-to-discover-drug-candidates-for-lung-cardiovascular-inflammatory-diseases/articleshow/74775451.cms
Subscribe to:
Post Comments (Atom)
Post a Comment